Universal Cells
Michael Dapp, Ph.D. is a Scientist II at Universal Cells with previous roles as a Research Scientist IV at the University of Washington. With a background in Pharmacology/Virology, Michael has a strong research and teaching experience, including being a Co-Instructor at the University of Washington Bothell and a Guest Lecturer at the University of Minnesota. Michael's education includes a Ph.D. from the University of Minnesota and a Bachelor of Science from the University of Wisconsin-Madison.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.